In 2021, Wang published an article titled “Molecular targeting therapies for neuroblastoma: Progress and challenges,” summarizing research on molecular pathways, such as MYCN, BIRC5, PHOX2B, LIN28B, and epigenetic regulatory factors, in the current understanding of the mechanisms underlying NB development (19). This evidence concerns the gene BIRC5 and neuroblastoma.